Showing results (11-20 of 304) with videos related to
Sort By:
Pageof 31
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Modulation of oestrogen action by receptor gene inhibitionT A Madden, D Barrow, R A McClelland, et al.International Journal of Cancer|February 7, 2001
Biological and clinical associations of c-jun activation in human breast cancerJ M Gee, A F Barroso, I O Ellis, et al.International Journal of Cancer|February 7, 2001
A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancerJ M Knowlden, J M Gee, J F Robertson, et al.The Journal of Pathology|January 12, 2000
Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancerJ M Gee, J F Robertson, I O Ellis, et al.The Histochemical Journal|March 1, 1995
Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNAP J Hepburn, E Glynne-Jones, L Goddard, et al.International Journal of Cancer|June 11, 1997
New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145H E Jones, C M Dutkowski, D Barrow, et al.The Prostate|September 11, 2001
Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathwaysH E Jones, D Barrow, C M Dutkowski, et al.Annals of the New York Academy of Sciences|January 1, 1990
Estrogen deprivation in breast cancer. Clinical, experimental, and biological aspectsR I Nicholson, K J Walker, N Bouzubar, et al.Endocrine-Related Cancer|August 23, 2005
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancerJ M Gee, J F Robertson, E Gutteridge, et al.The Journal of Pathology|July 9, 1999
p21(WAF1) expression and endocrine response in breast cancerR A McClelland, J M Gee, L O'Sullivan, et al.Pageof 31